Stockreport

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics

MAIA Biotechnology, Inc.  (MAIA) 
PDF MAIA seeks to advance two new THIO-derived telomere-targeting molecules to clinical trials CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) ( [Read more]